Skip to content
Governance Register

← US public companies

Avita Therapeutics, Inc.

SEC CIK 1762303 · RCEL · last insider filing 2026-06-12

Directors (from insider filings)

NameCapacity as filedFilings
Woody Joseph Fralin Director filed 2026 - 2026
Reed JAN Stern Director filed 2021 - 2026
Cook Jeremy Curnock Director filed 2020 - 2026
Mcnamara Robert Director filed 2023 - 2026
Tarnoff Michael E Director filed 2025 - 2026
Crowe Suzanne Director filed 2020 - 2026
Vance Cary Guy Director · President and CEO filed 2023 - 2026
Corbett James Director · CEO filed 2021 - 2025
Panaccio Lou Director filed 2020 - 2025
Perry Michael S Director · Chief Executive Officer filed 2020 - 2022
Drapeau Louis Director filed 2020 - 2021
Mcdonald Damien Director filed 2020 - 2020

Officers (from insider filings)

NameTitle as filedFilings
O'Toole David D CFO filed 2023 - 2026
Kelsey Nicole Chief Legal/Compliance Officer filed 2024 - 2026
Shiroma Donna General Counsel filed 2020 - 2024
Quick Andrew Chief Technology Officer filed 2020 - 2023
Ekins Sean Sr. VP of Finance filed 2020 - 2023
Holder Michael Chief Financial Officer filed 2021 - 2022
Liberto Erin Chief Commercial Officer filed 2020 - 2022
Mcgee Kathy M. Chief Operating Officer filed 2020 - 2022
Mcintyre David Chief Financial Officer filed 2020 - 2020
Rooney Timothy Chief Administrative Officer filed 2020 - 2020

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.